I think they probably could...
...pull it off, but aren't prepared or simply can't spend the money on another mult-million dollar trial.
Some of you need to quit reading only what you want to read.
The CEO has clearly stated several times that the Agenda Trial is the #1 priority for this company. They're not going to pump money into a new clinical trial while the Agenda Trial is ongoing and needs all of their resources to be completed.
Genta likely saw this as far back as 2007 and has never been financially prepared to start up a new confirmatory study for the treatment of CLL. Those dollars have been set aside for their #1 priority, the Agenda Trial.
So they are just exhausting every possibility through appeals, new data, etc., anything they can to gain approval from the FDA without having to kick in millions of dollars for a new trial.
The Agenda Trial can't be made to suffer, financially, when its' right at the finish line.
